Top Page
Fiji Kava Limited
(Sydney:CCO)
Fiji Kava Limited (CCO) vs. iShares MSCI Australia ETF (EWA)
Fiji Kava Limited Business Overview & Revenue Model
Fiji Kava Limited Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.03M | 8.03M | 4.26M | 1.78M | 2.05M | 1.16M |
| Gross Profit | 3.48M | 3.48M | 2.05M | -1.40M | 236.14K | 404.43K |
| EBITDA | -3.49M | -3.45M | -3.34M | -4.86M | -5.72M | -3.19M |
| Net Income | -3.99M | -3.99M | -3.73M | -5.24M | -5.92M | -3.39M |
Balance Sheet | ||||||
| Total Assets | 5.68M | 5.68M | 4.33M | 3.24M | 4.79M | 3.60M |
| Cash, Cash Equivalents and Short-Term Investments | 1.46M | 1.46M | 1.10M | 462.15K | 814.06K | 1.18M |
| Total Debt | 2.31M | 2.31M | 2.21M | 2.35M | 1.78M | 267.12K |
| Total Liabilities | 3.78M | 3.78M | 4.80M | 3.32M | 2.51M | 694.78K |
| Stockholders Equity | 1.90M | 1.90M | -466.84K | -87.53K | 2.28M | 2.91M |
Cash Flow | ||||||
| Free Cash Flow | -4.83M | -4.83M | -2.19M | -3.82M | -7.10M | -4.40M |
| Operating Cash Flow | -4.37M | -4.37M | -2.08M | -3.80M | -6.14M | -4.14M |
| Investing Cash Flow | -459.91K | -459.91K | -116.97K | -21.08K | -964.94K | -259.37K |
| Financing Cash Flow | 5.19M | 5.19M | 2.83M | 3.47M | 6.74M | 4.16M |
Fiji Kava Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
| ― | ― | ― | ― | ― | ― | 27.69% | |
| ― | AU$8.02M | -2.78 | -77.48% | ― | 63.30% | 70.00% | |
| ― | AU$8.20M | ― | -60.84% | ― | -18.70% | 20.83% | |
| ― | AU$12.23M | -6.67 | -555.97% | ― | 88.48% | 51.61% | |
| ― | AU$4.28M | ― | ― | ― | -21.84% | 79.99% |
Fiji Kava Limited Corporate Events
The Calmer Co International Limited has announced a change in the director’s interest notice, specifically involving Zane Yoshida. The announcement details the acquisition of 20 million fully paid ordinary shares (FPOS) by UMI7 Investments Pty Ltd, where Mr. Yoshida holds an indirect interest as a director and beneficiary. This move reflects an increase in the director’s indirect holdings, potentially strengthening his influence and stake in the company.
The Calmer Co. International Limited has issued 47 million fully paid ordinary shares as part of its share plan, without requiring disclosure to investors under specific provisions of the Corporations Act 2001. This strategic move, authorized by the company’s Board of Directors, aligns with regulatory compliance and suggests a potential strengthening of the company’s financial position, impacting its market operations and stakeholder interests.
The Calmer Co International Limited, identified by the ASX issuer code CCO, has announced the quotation of 47,000,000 ordinary fully paid securities on the Australian Securities Exchange (ASX). These securities, issued under an employee incentive scheme, are set to be quoted despite any transfer restrictions, potentially enhancing the company’s market liquidity and investor appeal.
Fiji Kava Limited has reported significant financial growth with $8 million in revenue for FY25, marking an 86% year-over-year increase and nearly fivefold growth over two years. The company is on track to achieve breakeven by 2026, highlighting its strong positioning and potential impact in the kava industry.
The Calmer Co. International Limited has announced a record-breaking quarterly revenue of $2.4 million for the first quarter of FY26, marking a 26% increase from the previous quarter. This growth is driven by strong sales in Australia and the USA, with significant contributions from retail distribution and new product launches on Amazon. The company has also secured $700,000 as part of a convertible note issuance to bolster inventory and growth initiatives, positioning it well to achieve breakeven. The company’s diversified sales and marketing strategies, along with its expanding B2B business, underscore its potential in the global kava market.
The Calmer Co International Limited has announced a proposed issue of 1,400,000 convertible notes, with the issuance date set for September 30, 2025. This move is part of a placement or other type of issue, and the company has applied for these securities to be quoted on the ASX, pending approval. This issuance is expected to impact the company’s financial operations by potentially increasing its capital base, which could enhance its market positioning and provide new opportunities for stakeholders.
The Calmer Co. International Limited has secured $1.4 million through a convertible note raise, with the first tranche of $700,000 already committed. This funding will be used to build inventory and support working capital as the company continues its growth trajectory, particularly in the US market where it has seen a 21% increase in revenue. The involvement of Applied Food Sciences as a strategic investor underscores confidence in The Calmer Co.’s expansion strategy, especially in the wholesale channel, and aligns with its goal of building a global platform for its nutraceutical business.
The Calmer Co. International Limited reported strong sales momentum in July and August 2025, following a successful operational turnaround in the second half of FY25. The company reduced total expenses by 27% and improved its operating loss by 33%, driven by cost controls and price increases in major Australian retailers. Sales in July reached $715k, with August sales increasing by 17% to $838k, bringing the annualized sales run-rate to over $10 million. Notably, Amazon USA sales grew by 12% month-on-month, enhancing the company’s market share in the US kava category. The introduction of new products, such as kava tinctures and flavored Taki Mai shots, has contributed to this growth, positioning the company for continued expansion across retail, B2B, and eCommerce channels.
The Calmer Co. International Ltd has released its corporate governance statement for the financial year ending 30 June 2025, which is available on their website. The statement confirms the company’s adherence to ASX Corporate Governance Council recommendations, detailing the roles and responsibilities of the board and management, and ensuring transparency in governance practices. This announcement reinforces the company’s commitment to maintaining high governance standards, potentially enhancing stakeholder trust and positioning the company favorably within the industry.
Fiji Kava Limited, operating under The Calmer Co. International Limited, reported its financial results for the year ending June 30, 2025. The company saw an 88% increase in revenues from ordinary activities, totaling $8,034,682. However, it also reported a 7% increase in losses after tax, amounting to $3,992,277. No dividends were declared for the period, indicating a focus on reinvestment or financial restructuring.
The Calmer Co. has secured an expanded lease for its Navua facility in Fiji, ensuring long-term operational stability and supporting its growth strategy. The lease agreement, which includes a three-year term with an option to extend until 2031, allows the company to redirect capital initially intended for property acquisition towards accelerating growth initiatives, particularly as it enters the US market.
The Calmer Co International Limited announced a change in the director’s interest, specifically involving John Homewood, who is a director of Homewood Venture Capital Pty Ltd and Ace Property Holdings Pty Ltd. The change involved an acquisition of 1,472,175 fully paid ordinary shares (FPOS) by Homewood Venture Capital Pty Ltd, increasing their total holdings to 135,000,000 FPOS. This transaction, conducted as an on-market trade, reflects a strategic move by the director to increase his stake in the company, potentially signaling confidence in the company’s future prospects.
The Calmer Co. International Limited has announced a record monthly sales result in the Coles retail channel for July 2025, with an 81% increase in sales to $344,000. This growth, driven by an expanded store footprint, strong sell-through rates, and targeted in-store promotions, underscores the company’s successful national expansion within Coles stores and its position as a leader in the natural wellness and alcohol alternatives category. The company remains focused on driving sales velocity within major national retailers and enhancing consumer engagement across its brands, with growth in the Australian retail channel being a key pillar of its strategy for sustainable revenue growth and category leadership.
The Calmer Co. has presented its Q4FY25 results, highlighting its focus on leveraging global opportunities in the kava market. The company’s strategic distribution through e-commerce and retail channels, along with a transparent supply chain, positions it strongly in markets such as the USA, Australia, New Zealand, China, and the Pacific Islands, potentially enhancing its market presence and stakeholder value.
The Calmer Co. International Limited, operating in the wellness and natural products industry, reported significant financial progress in Q4 FY25, focusing on sustainable and profitable growth. The company achieved a 6% increase in quarterly revenue, driven by strong performance in eCommerce, particularly on Amazon USA, and successful retail channel expansion into Woolworths. The transition to the Acuity platform is expected to enhance operational efficiency and support the company’s strategy to diversify sales channels and leverage its CO₂ extraction capability, positioning it well for accelerated growth in FY26.
The Calmer Co International Limited has announced a change in the director’s interest, specifically involving John Homewood. Mr. Homewood, through his associations with Homewood Venture Capital Pty Ltd and Ace Property Holdings Pty Ltd, has increased his holdings of Fully Paid Ordinary Shares (FPOS) by acquiring 13,527,825 shares, bringing the total to 133,527,825 FPOS. This acquisition was made through an on-market trade at a value of $0.003 per share. The change in Mr. Homewood’s interest could potentially impact the company’s market perception and stakeholder confidence, as it reflects a significant increase in his investment in the company.